Alerts will be sent to your verified email
Verify Email
VEERHEALTH
|
Veerhealth Care
|
Biofil Chem & Pharma
|
Vilin Bio Med
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.69 % | 4.39 % | 3.09 % |
|
5yr average Equity Multiplier
|
1.35 | 2.06 | 1.6 |
|
5yr Average Asset Turnover Ratio
|
0.51 | 0.95 | 0.68 |
|
5yr Avg Net Profit Margin
|
3.95 % | 2.38 % | 2.8 % |
|
Price to Book
|
2.66 | 2.74 | 0.0 |
|
P/E
|
112.65 | 21.02 | 32.85 |
|
5yr Avg Cash Conversion Cycle
|
43.62 Days | 75.63 Days | 211.9 Days |
|
Inventory Days
|
56.8 Days | 28.27 Days | 70.76 Days |
|
Days Receivable
|
78.02 Days | 389.8 Days | 147.75 Days |
|
Days Payable
|
63.05 Days | 203.89 Days | 44.01 Days |
|
5yr Average Interest Coverage Ratio
|
208.02 | 23.53 | 1.77 |
|
5yr Avg ROCE
|
3.74 % | 6.37 % | 8.99 % |
|
5yr Avg Operating Profit Margin
|
0.37 % | 3.78 % | 9.07 % |
|
5 yr average Debt to Equity
|
0.07 | 0.03 | 0.47 |
|
5yr CAGR Net Profit
|
0.52 % | -14.7 % | 12.89 % |
|
5yr Average Return on Assets
|
2.06 % | 2.37 % | 1.89 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
31.5 % | 46.79 % | 59.57 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.74 % | -0.03 % | -4.95 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Veerhealth Care
|
Biofil Chem & Pharma
|
Vilin Bio Med
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|